Xynomic Pharmaceuticals (XYNPW) Form 4 Bison Capital Acquisition / Peixin Xu ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Xu Peixin

(Last) (First) (Middle)

609-610 21ST CENTURY TOWER, NO. 40

LIANGMAQIAO ROAD, CHAOYANG DISTRICT

(Street)

BEIJING, F4 10016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bison Capital Acquisition Corp. [ BCACU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
President

3. Date of Earliest Transaction (Month/Day/Year)
06/28/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary share, no par value	06/28/2017		P(1)		39,375(1)	A	(1)	1,519,600	I(3)	(3) See Footnote

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Rights	$0	06/28/2017		P(1)		39,375		(2)	(2)	Ordinary share	3,937(2)	(1)	401,875	I(3)	(3) See Footnote
Warrants	$11.5	06/28/2017		P(1)		19,688		(2)	(2)	Ordinary share	19,688(2)	(1)	200,938	I(3)	(3) See Footnote

Explanation of Responses:

1. In connection with the exercise of the over-allotment option in full on June 28, 2017, Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 39,375 units of Bison Capital Acquisition Corp., a British Islands company (the "Company"), at a price of $10.00 per unit, pursuant to certain amended and restated unit subscription agreement dated June 19, 2017 between the Company and Bison Capital (the "Unit Subscription Agreement").

2. Pursuant to the Unit Subscription Agreement, each unit consists of one share, one right and one-half of one warrant. Each right entitles the holder to receive one-tenth of one share upon consummation of the Company's initial business combination, expiring at the 5th anniversary of the business combination. Each whole warrant entitles the holder to one Ordinary Share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination.

3. Mr. Peixin Xu holds 20% ownership of Bison Capital and his spouse, Ms. Fengyun Jiang, holds 80% ownership of Bison Capital. With Ms. Jiang, Mr. Xu jointly and indirectly control 1,519,600 ordinary shares of the Company through his joint and direct ownership of Bison Capital.

	/s/ Peixin Xu	06/28/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.